Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Data Extraction Two independent researchers extracted data and evaluated any disagreement was resolved through open discussion with a third independent investigator (KhM)
Key takeaways Ozempic is a medication thats FDA-approved for Type 2 diabetes and is prescribed off-label for weight loss
Real Confidence
Fixed-dose combinations could optimize outcomes, particularly for patients with advanced disease or those unresponsive to monotherapy
Sales of Ozempic increased 77% to about $8.5 billion, and sales of Wegovy more than quadrupled, reaching about $880 million
Science 307, 19151920
US$ 26.18
US$ 22.10
US$ 23.52
US$ 23.73
US$ 21.97
